Medapti Suun kautta annettavan lääkkeen ruiskusovitin – tekijä Dorota Dyk

Muotoilu Medapti Suun kautta annettavan lääkkeen ruiskusovitin, tekijä Dorota Dyk, on erittäin arvostettu voittaja kilpailukategoriassa Vauvatuotteet, palkinto 2021 Pronssipalkinto A' Design Award.

PronssiVauvatuotteet· 2021

Medapti Suun kautta annettavan lääkkeen ruiskusovitin

Suunnittelija: Dorota Dyk

Asiakas: Medapti

Palkinnon Pronssipalkinto A' Design Award voittaja kategoriassa Vauvatuotteet

18,093

Vahvistettu palkintovoittaja

Vahvista palkinnon tila muotoilulle #123693

Vieraile sivustolla Näytä A' Design Award -sivustolla Lehdistötiedote Palkintomerkki

Värit

Muotoilu

Tietoa: Medapti Suun kautta annettavan lääkkeen ruiskusovitin

Medapti on vauvoille tarkoitettu suun kautta annettavan lääkkeen ruiskusovitin. Medapti tekee nestemäisen lääkkeen antamisesta yksinkertaisempaa kuin ruiskun käyttämisestä yksinään. Yksiosainen tuote muodostuu pehmeästä suusuojasta ja putkesta. Täytetty ruisku työnnetään putkeen, joka pitää ruiskun paikoillaan voimaa käyttämättä. Kulmassa oleva putki ohjaa lääkkeen poskeen kurkun takaosan sijaan. Suusuoja estää ruiskua menemästä liian syvälle suuhun. Medapti on valmistettu lääketieteellisen laadun, BPA-vapaasta termoplastisesta elastomeerista ja siinä on tuuletusreikiä.

Tunnustus

Tietoa palkinnosta: Pronssipalkinto A' Design Award

Medapti Suun kautta annettavan lääkkeen ruiskusovitin on Pronssipalkinnon A' Design Award -voittaja, erittäin arvostettu tunnustus, joka myönnetään erinomaisille designeille, joita luonnehtivat luovuus, nerokkuus ja oveluus. Pronssivoittajat ovat runsaan taitavia ja silmiinpistävän luovia taiteellisia tuotoksia, jotka todistavat suunnittelijoidensa laajaa kokemusta, mielikuvitusta ja kekseliäisyyttä. Medapti Suun kautta annettavan lääkkeen ruiskusovitin:n odotetaan olevan korkeassa arvossa pidetty, ihailtu ja rakastettu esine, joka on huomattavan ammattimainen ja innovatiivinen. Tämä Pronssipalkinnon A' Design Award -voittajadesign sisällyttää itseensä parhaita käytäntöjä taiteessa, tieteessä, designissa ja teknologiassa ja on erinomainen huomiollaan yksityiskohtiin. Medapti Suun kautta annettavan lääkkeen ruiskusovitin tyydyttää upeasti tarpeita, koskettaa haluja, viehättää tunteita ja vetoaa uteliaisuuteen.

Muotoilun taustalla

Lehdistöpaketti

Suunnittelijan toimittamat tekijätiedot, tiimin jäsenet ja tekniset yksityiskohdat.

Ainutlaatuiset ominaisuudet: Administering oral medication to babies can be problematic. Medapti surpasses the current products by its simplicity and a unique design which directs the syringe to the side of the mouth. The syringe is simply inserted inside the tube which is at an angle and directs the medication to the cheek, not the back of the throat. The mouth guard helps to position the syringe and ensures the syringe does not go too far down the mouth. Softer material is gentle on the gums. Medapti was designed with safety in mind. It passes not only a choking test but a more rigorous air-obstruction safety test.
Mitat ja pakkaus: Medapti is 6 gram in weight and has the following dimensions: 62mm x 50mm x 43mm. It comprises of a mouthguard and a tube where the syringe is inserted. The tube is designed in a way that holds the syringe in place, but no force needs to be used to push or remove it. The tube is at an angle to direct the syringe to the side of baby's mouth. Additional features include ventilation holes and a holder to pull Medapti out if it ever got stuck in the mouth (although it is unlikely to happen, the design takes this eventuality into consideration). The product is packaged in a fully recyclable cardboard box.
Tunnisteet: baby product, baby essential, baby medication, baby syringe, baby medicine, baby medicine dispenser, nursery product
Tuotantoteknologia: The original concept was simply created with clay and cardboard which in result led to approximately 50 design modifications and numerous rounds of 3D printed and vacuum cast prototypes to create a functional product. Safety standards had a major influence on the final shape and size. Consequently, a 2-cavity, hot runner mould made from steel has been built. Medapti units are made out of medical grade, BPA-free thermoplastic elastomer (which can be fully recycled providing there is a facility to do so).
Muotoiluhaaste: The main challenge was to pass the air-obstruction test without compromising the visual aspects of the design by making the product too large. The syringe tube design was also problematic. It was important that the syringe stays securely inside the tube without the need of using too much force to insert it. An inner "ring" was added, and various sizes and shapes were tested, until the goal was achieved. The other major challenge was no existing safety standards for such a novel product. It was resolved by talking to testing houses, safety standards specialists and health professionals.
Tutkimus: Medapti is an innovative product, therefore no standards for this product exist yet. Medapti worked closely with the safety testing companies, who advised on what standards the product should try to comply with. The main aim was to pass the air obstruction test and meet as many clauses of the EN1400 soother standard as possible. The size and shape were designed so the adapter does not fit through the air obstruction gauge. Furthermore, ventilation holes and a holder were added as additional safety features.
Inspiraatio: When my children were babies, I struggled to give them medicine, especially my youngest who refused to take it. Further research showed that administering medication to babies can be a real issue, with parents worrying about babies choking on medicine and not giving a correct dose if a baby spits it out. I wanted to create a simple to use solution. Medapti concept gained interest from international media, health professionals and hospitals including Great Ormond Street, Alder Hey, Sheffield and Manchester Children Hospitals in England.
Projektin kesto: The project started in 2013 in England. It was first publicly presented in Richard Branson's competition where it received a lot of traction and media attention. In 2018, Medapti was chosen as a BPA Concept&Innovation finalist and as a result, secured a stand at the Harrogate International Nursery Fair where prototypes were exhibited. Medapti will launch in the UK and on Amazon marketplace in April 2021. Additionally, it will be sold on a license in Poland, Scandinavia and other Eastern European countries in the second half of 2021.
Toimintaprosessi: Dispensing medicine with the syringe alone can be problematic due to babies moving around or refusing the medication. It can be difficult to place the syringe in the mouth and the syringe can be inserted too far down the throat. Moreover, the medicine can be accidentally dispensed to the back of the throat. A hard plastic syringe can also hurt the gums. Medapti is an improvement to a syringe and makes it easier to place the syringe in baby's mouth, ensuring it does not go too far as well as helps to direct it to the cheek.
Patentit: Patented. GB1320255.1. Medapti Ltd. 2017. UK
Patent Pending. EP3068362A1/WO2015071476A1. Medapti Ltd. 2013. EU
Patent Pending. US2016279031A1. Medapti Ltd. 2013. USA
Trademark 017921466 (2018) Medapti Ltd.
Trademark UK00003217910 (2017) Medapti Ltd.
Trademark 79248534 (2019) Medapti Ltd.
Trademark: 1981688 (2018) Medapti Ltd.
Trademark 32979654 (2019 Medapti Ltd.
Trademark UK00003573861 (2020) Medapti Ltd.
Trademark UK00003573864 (2020) Medapti Ltd.
Design UK 6110454 (2020) Medapti Ltd.
EUIPO RCD 008173421-0001 (2020) Medapti Ltd.
Kuvalähteet: Image #1 : Photographer Julia Michalczewska, Medapti product photo, 2021
Image #2 : Photographer Julia Michalczewska, Medapti inside baby's mouth front, 2021
Image #3 : Photographer Julia Michalczewska, Medapti tube outside baby's mouth, 2021
Image #4 : Photographer Julia Michalczewska, Medapti inside baby's mouth top angle, 2021
Image #5 : Photographer Julia Michalczewska, Medapti how to use with syringe, 2021